DexTech Medical AB (XSAT:DEX) 3-Year EBITDA Growth Rate : 9.60% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is DexTech Medical AB 3-Year EBITDA Growth Rate?

DexTech Medical AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.08.

During the past 3 years, the average EBITDA Per Share Growth Rate was 9.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -8.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -23.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of DexTech Medical AB was 9.60% per year. The lowest was -49.40% per year. And the median was -20.75% per year.

Competitive Comparison of DexTech Medical AB's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, DexTech Medical AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DexTech Medical AB's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DexTech Medical AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where DexTech Medical AB's 3-Year EBITDA Growth Rate falls into.

DexTech Medical AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

DexTech Medical AB (XSAT:DEX) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

DexTech Medical AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of DexTech Medical AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

DexTech Medical AB (XSAT:DEX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DexTech Medical AB (XSAT:DEX) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37

Website

https://www.dextechmedical.com

DexTech Medical AB develops candidate medications with applications within urological oncology, for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases. The company has a strong clinical base with valuable specialist expertise from research laboratories and manufacturing to clinical oncology.